CPhT CONNECT™ Magazine - Volume 5 Issue 2

CONTINUING EDUCATION

carboplatin carmustine chlorambucil

Antineoplastic agents Antineoplastic agents Antineoplastic agents

Yes Yes Yes

No No No

IARC Group 2A carcinogen

IARC Group 1 carcinogen; NTP “known to be human carcinogen” IARC Group 2A carcinogen; NTP “reasonably anticipated to be a human carcinogen”

chloramphenicol

Chloramphenicol

No

No

cidofovir cisplatin

Nucleoside and nucleotide Yes

No No

Antineoplastic agents

Yes

IARC Group 2A carcinogen; NTP “reasonably anticipated to be a human carcinogen”

cladribine clofarabine

Antineoplastic agents Antineoplastic agents

Yes Yes Yes

No No No

cyclophosphamide

Antineoplastic agents, immu- nosuppressive agents Anti-inflammatory agents; immunosuppressive agents; immunomodulatory agents; disease-modifying antirheu- matic drugs

IARC Group 1 carcinogen; NTP “known to be human carcinogen” IARC Group 1 carcinogen; NTP “known to be human carcinogen”

cyclosporine

No

No

cytarabine dacarbazine

Antineoplastic agents Antineoplastic agents

Yes Yes

No No

IARC Group 2B; NTP “reasonably anticipated to be a human carcino- gen”*

dactinomycin

Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents

Yes Yes Yes Yes Yes

No No No No No No No No

dasatinib

daunorubicin

IARC Group 2B

decitabine

dexrazoxane

Protective agents

diethylstilbestrol

NA

No

IARC Group 1 carcinogen; NTP “known to be a human carcinogen”

docetaxel doxorubicin

Antineoplastic agents Antineoplastic agents

Yes Yes

IARC Group 2A carcinogen. NTP “reasonably anticipated to be a human carcinogen”*

enfortumab vedotin

Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents

Yes Yes Yes Yes

Yes

epirubicin

No No No No

eribulin mesylate

estramustine

estrogen/progesterone combinations estrogens, conjugated

Contraceptives; estrogens; progestins Estrogens; bone resorption inhibitors

No

IARC Group 1 carcinogen; NTP “known to be a human carcinogen” NTP “known to be a human carcin- ogen”

No

No

etoposide everolimus

Antineoplastic agents

Yes Yes

No No

IARC Group 1 carcinogen

Antineoplastic agents; immu- nosuppressive agents

fam-trastuzumab-deruxte- can

Antineoplastic agents

Yes

Yes

CPhT CONNECT www.cphtconnect.com

37

Made with FlippingBook - PDF hosting